Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Ibrunat 140 mg Capsule (containing Ibrutinib) is a targeted cancer therapy, specifically a Bruton's tyrosine kinase (BTK) inhibitor used for blood cancers like CLL and MCL. It works by binding permanently to the BTK protein, interrupting signals that allow malignant B-cells to survive and multiply, effectively reducing tumor size and slowing disease progression.
| Strength | 140mg |
| Route | Oral (capsule) |
| Storage | 20-25°C |
| Treatment | Mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia) |
| Packaging Size | 30 CAPSULES |
| Main Ingedients | Ibrutinib |